In recent years, with the legalization of medical marijuana in a number of states, the interest in developing and researching marijuana for medical purposes has increased.
Jessica Robinson-Papp, MD, MS, professor of neurology, Icahn School of Medicine at Mount Sinai, is one of the physicians with an interest in medical marijuana and its potential uses in the treatment of neurological conditions.Â
As many of you may recall, Dr. Robinson-Papp presented at our New York Patient Conference last October and co-wrote a blog on medical marijuana which was posted on FPN’s website a couple months ago.Â
The Next Generation of Researchers Focusing on Peripheral Neuropathy!
FPN views with great hope that a young and brilliant scientific mind has been recognized for her research study that focuses on PN.
SoCalBio’s 2019 Southern California BioGENEius Challenge winner was announced in May 2019. The winning project focused on Photobiomodulation as a potential therapy for PN.
Ninth grader Nadia Ansari’s research identified a gene (mpv17) that may help PBM regrow and restore function to sensory nerves. During experimentation,
she showed that nerve fiber growth increased 536 percent when the mpv17 gene was present.
Women Twice as Likely to Report Neuropathic Pain in Type 2 Diabetes
A recent study initially looking to connect the likelihood of peripheral neuropathic pain with a deficit of Vitamin D made an unexpected discovery: While there seemed not to be a statistically relevant correlation between Vitamin D and diabetic nerve pain, it was noted that women with type 2 diabetes were 2.4 times more likely to report neuropathic pain than men, according to findings from a cross-sectional study published in BMJ Open Diabetes Research & Care.
in developing and researching marijuana for medical purposes has increased.
The Next Generation of Researchers Focusing on Peripheral Neuropathy!
Women Twice as Likely to Report Neuropathic Pain 
A study on the effectiveness of Duloxetine and Gabapentin .png)
